Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Cancer type

Germ cell

Germ cell tumors.

Must-know

No randomized trial or major prospective MRD validation cohort in germ cell tumors was identified for this list.

Listed when a study is a randomized or prospective interventional ctDNA or MRD trial, is cited in NCCN or ESMO guidance, or is a prospective validation cohort in a high-impact journal. Shorter lists mean fewer studies met that rule. No test is ranked.

Accruing studies for Germ cell

Trials

  • Recruiting · Not applicable

    NCT07401316 ctDNA in stage I, II, and III germ cell tumors

    Diagnostic study collecting serial ctDNA in high-risk stage I, stage II, and stage III germ cell tumors to estimate positive predictive value for relapse, retroperitoneal histology, and progression after chemotherapy.